Blood-Based Biomarkers Among Notable Alzheimer’s Advances
Blood-based Alzheimer’s biomarkers enable earlier, less invasive diagnosis, expanding screening and research opportunities while raising concerns about accuracy, equity, access, counseling, and health system readiness for implementation.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.